Graves' Hyperthyroidism Following Transient Thyrotoxicosis during Interferon Therapy for Chronic Hepatitis Type C
We report a case of Graves' hyperthyroidism induced by long-term interferon (IFN) therapy.A 52-year-old woman suffered from chronic active hepatitis type C and was treated with a total of 456×106 units of IFN-α for 23 weeks. During the 12th week of treatment she showed transient thyrotoxicosis....
Saved in:
Published in: | Internal Medicine Vol. 34; no. 1; pp. 58 - 60 |
---|---|
Main Authors: | , , , , , , , , |
Format: | Journal Article |
Language: | English |
Published: |
Tokyo
The Japanese Society of Internal Medicine
1995
Japanese Society of Internal Medicine |
Subjects: | |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Abstract | We report a case of Graves' hyperthyroidism induced by long-term interferon (IFN) therapy.A 52-year-old woman suffered from chronic active hepatitis type C and was treated with a total of 456×106 units of IFN-α for 23 weeks. During the 12th week of treatment she showed transient thyrotoxicosis. One week after the termination of IFN therapy, TSH-receptor antibodies became positive and subsequently she showed Graves' hyperthyroidism. This case showed sequential manifestation from transient thyrotoxicosis to the appearance of TSH-receptor autoantibodies, and then the occurrence of Graves' hyperthyroidism during IFN therapy. The course of this case may be useful in the understanding of the pathogenesis of autoimmune hyperthyroidism. (Internal Medicine 34: 58-60, 1995) |
---|---|
AbstractList | We report a case of Graves' hyperthyroidism induced by long-term interferon (IFN) therapy. A 52-year-old woman suffered from chronic active hepatitis type C and was treated with a total of 456 x 10(6) units of IFN-alpha for 23 weeks. During the 12th week of treatment she showed transient thyrotoxicosis. One week after the termination of IFN therapy, TSH-receptor antibodies became positive and subsequently she showed Graves' hyperthyroidism. This case showed sequential manifestation from transient thyrotoxicosis to the appearance of TSH-receptor autoantibodies, and then the occurrence of Graves' hyperthyroidism during IFN therapy. The course of this case may be useful in the understanding of the pathogenesis of autoimmune hyperthyroidism. We report a case of Graves' hyperthyroidism induced by long-term interferon (IFN) therapy.A 52-year-old woman suffered from chronic active hepatitis type C and was treated with a total of 456×106 units of IFN-α for 23 weeks. During the 12th week of treatment she showed transient thyrotoxicosis. One week after the termination of IFN therapy, TSH-receptor antibodies became positive and subsequently she showed Graves' hyperthyroidism. This case showed sequential manifestation from transient thyrotoxicosis to the appearance of TSH-receptor autoantibodies, and then the occurrence of Graves' hyperthyroidism during IFN therapy. The course of this case may be useful in the understanding of the pathogenesis of autoimmune hyperthyroidism. (Internal Medicine 34: 58-60, 1995) |
Author | MIZUO, Hitoshi MATSUYA, Kumiko MASHIO, Yasuo MATSUDA, Akira IRIUDA, Yoshiyori KOIZUMI, Shigeki BENIKO, Mutsuo MIZUMOTO, Hiroaki IKOTA, Akemi |
Author_xml | – sequence: 1 fullname: KOIZUMI, Shigeki organization: the Department of Internal Medicine, Kin-ikyo Sapporo Kitaku Hospital – sequence: 2 fullname: MASHIO, Yasuo organization: the Department of Internal Medicine, Kin-ikyo Sapporo Kitaku Hospital – sequence: 3 fullname: MIZUO, Hitoshi organization: the Department of Internal Medicine, Kin-ikyo Sapporo Kitaku Hospital – sequence: 4 fullname: MATSUDA, Akira organization: Kin-ikyo Chuo Hospital – sequence: 5 fullname: MATSUYA, Kumiko organization: Kin-ikyo Chuo Hospital – sequence: 6 fullname: MIZUMOTO, Hiroaki organization: Kin-ikyo Chuo Hospital – sequence: 7 fullname: IKOTA, Akemi organization: Kin-ikyo Chuo Hospital – sequence: 8 fullname: BENIKO, Mutsuo organization: Kin-ikyo Chuo Hospital – sequence: 9 fullname: IRIUDA, Yoshiyori organization: the Department of Internal Medicine, Kin-ikyo Sapporo Kitaku Hospital |
BackLink | http://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=3476404$$DView record in Pascal Francis https://www.ncbi.nlm.nih.gov/pubmed/7718983$$D View this record in MEDLINE/PubMed |
BookMark | eNplkMFuGyEQhlGVKHXSPkIiDpV6Wgd2dpflWFlNHClSLu55RWCIidawBdLWb19WtnxILoPE9w0z_JfkzAePhNxwtqx5J2-dzxi9GndonHYel9As2_4TWXBoZCVqaM_IgkneV3Upn8llSq-MQS9kfUEuhOC97GFBft9H9QfTd7reTxjzdh-DMy7t6F0Yx_DX-Re6iconhz7TzYxz-Od0SC5R8xZn_jBvYjEGXwSMatpTGyJdbcuN03SNk8ouF39TRtDVF3Ju1Zjw6_G8Ir_ufm5W6-rx6f5h9eOx0q3oc8U17xoFUFvA2mopawYSNKAyouk6IxRoZpQxgPDc9h3jyljgUthaMskQrkh3eFfHkFJEO0zR7VTcD5wNc4TD-wgHaIa2L43Xh8bp7bmgU9sxs8K_HblKWo22xKNdOmnQiK5hTdGeDtpryuoFT1zF7PSIH6bz8sV5A34obX8y9VbFAT38B9tfoNY |
CitedBy_id | crossref_primary_10_1515_JPEM_2007_20_2_237 crossref_primary_10_2957_kanzo_51_300 crossref_primary_10_1097_01_rlu_0000170014_35693_6c crossref_primary_10_1507_endocrj_52_293 crossref_primary_10_1007_BF03259299 crossref_primary_10_1089_107999099314450 crossref_primary_10_3346_jkms_2011_26_12_1638 |
ContentType | Journal Article |
Copyright | The Japanese Society of Internal Medicine 1995 INIST-CNRS |
Copyright_xml | – notice: The Japanese Society of Internal Medicine – notice: 1995 INIST-CNRS |
DBID | IQODW CGR CUY CVF ECM EIF NPM AAYXX CITATION |
DOI | 10.2169/internalmedicine.34.58 |
DatabaseName | Pascal-Francis Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed CrossRef |
DatabaseTitle | MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) CrossRef |
DatabaseTitleList | MEDLINE |
Database_xml | – sequence: 1 dbid: ECM name: MEDLINE url: https://search.ebscohost.com/login.aspx?direct=true&db=cmedm&site=ehost-live sourceTypes: Index Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine |
EISSN | 1349-7235 |
EndPage | 60 |
ExternalDocumentID | 10_2169_internalmedicine_34_58 7718983 3476404 article_internalmedicine1992_34_1_34_1_58_article_char_en |
Genre | Journal Article Case Reports |
GroupedDBID | --- .55 29J 2WC 3O- 53G 5GY 7.U AAPBV AAUGY ACPRK ADBBV ADRAZ AENEX AFRAH ALMA_UNASSIGNED_HOLDINGS AOIJS BAWUL CS3 DIK DU5 EBS EJD EMOBN F5P HYE JSF JSH M48 M~E OK1 P2P RJT RNS RPM RZJ TKC TR2 X7M XSB IQODW CGR CUY CVF ECM EIF NPM PGMZT AAYXX CITATION |
ID | FETCH-LOGICAL-c578t-1c164a332f3e2fc9920393c3ead7466d7a3c0dadd3e3b58601adf3197f29090e3 |
ISSN | 0918-2918 |
IngestDate | Fri Aug 23 04:02:17 EDT 2024 Sat Sep 28 08:36:47 EDT 2024 Sun Oct 29 17:10:34 EDT 2023 Thu Aug 17 20:27:31 EDT 2023 |
IsDoiOpenAccess | true |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 1 |
Keywords | Endocrinopathy Human Toxicity Hyperthyroidism Thyroid diseases Autoimmune disease Transitory Case study Immunomodulator Chemotherapy Graves disease Antiviral Female Interferon Long lasting |
Language | English |
License | CC BY 4.0 |
LinkModel | OpenURL |
MergedId | FETCHMERGED-LOGICAL-c578t-1c164a332f3e2fc9920393c3ead7466d7a3c0dadd3e3b58601adf3197f29090e3 |
OpenAccessLink | https://www.jstage.jst.go.jp/article/internalmedicine1992/34/1/34_1_58/_article/-char/en |
PMID | 7718983 |
PageCount | 3 |
ParticipantIDs | crossref_primary_10_2169_internalmedicine_34_58 pubmed_primary_7718983 pascalfrancis_primary_3476404 jstage_primary_article_internalmedicine1992_34_1_34_1_58_article_char_en |
PublicationCentury | 1900 |
PublicationDate | 1995 1995-Jan 1995-00-00 |
PublicationDateYYYYMMDD | 1995-01-01 |
PublicationDate_xml | – year: 1995 text: 1995 |
PublicationDecade | 1990 |
PublicationPlace | Tokyo |
PublicationPlace_xml | – name: Tokyo – name: Japan |
PublicationTitle | Internal Medicine |
PublicationTitleAlternate | Intern. Med. |
PublicationYear | 1995 |
Publisher | The Japanese Society of Internal Medicine Japanese Society of Internal Medicine |
Publisher_xml | – name: The Japanese Society of Internal Medicine – name: Japanese Society of Internal Medicine |
References | 4) Lisker-Melman M, Di Bisceglie AM, Usala SJ, Weintraub B, Murray LM, Hoofnagle JH. Development of thyroid disease during therapy of chronic viral hepatitis with interferon alfa. Gastroenterol 102: 2155, 1992. 7) Abe T, Suga M, Ono A, et al. A case of hyperthyroidism appeared during interferon treatment for chronic hepatitis C. Nippon Shokakibyo Gakkai Zasshi 90: 818, 1993 (in Japanese). 3) Burman P, Karlsson FA, Oberg K, Aim G. Autoimmune thyroid disease in interferon-treated patients. Lancet 100, 1985. 5) Papo T, Oksenhendler E, Izembart M, Leger A, Clauvel J-P. Antithyroid hormone antibodies induced by interferon-α. J Clin Endocrinol Metab 75: 1484, 1992. 10) Golub SH. Immunological and therapeutic effects of interferon treatment of cancer patients. Clin Immunol Allergy 4: 377, 1984. 14) Daniels HM, Meager A, Eddleston ALWF, et al. Spontaneous production of tumour necrosis factor a and interleukin-16 during interferon-α treatment of chronic HBV infection. Lancet 335: 875, 1990. 6) Taniguchi Y, Murakami T, Nakanishi K, et al. Two cases of hypothyroidism associated with alpha-interferon therapy. Intern Medicine 31: 373, 1992. 1) Davis TF. New thinking on the immunology of Graves' disease. Thyroid Today 15: 1, 1992. 13) Mayet W-J, Hess G, Gerken G, et al. Treatment of chronic type B hepatitis with recombinant α-interferon induces autoantibodies not specific for autoimmune chronic hepatitis. Hepatology 10: 24, 1989. 8) Mashio Y, Beniko B, Ikota A, Mizumoto H, Kunita H. Treatment of hyperthyroidism with a small single daily dose of methimazole. Acta Endocrinologica (Copenh) 119: 139, 1988. 11) Hanafusa T, Pujol-Borrell R, Chiovato L, et al. Aberrant expression of HLA-DR antigen on thyrocytes in Graves' disease: relevance for autoimmunity. Lancet 2: 1111, 1983. 12) Jansson R, Karlsson A, Forsum U. Intrathyroidal HLA-DR expression and T lymphocyte phenotypes in Graves' thyrotoxicosis, Hashimoto's thyroiditis and nodular colloid goitre. Clin Exp Immunol 58: 264,1984. 17) Wartofsky L. Graves' disease with thyrotoxicosis following subacute thyroiditis. Am J Med 83: 761, 1987. 16) Werner SC. Graves' disease following acute (subacute) thyroiditis. Arch Intern Med 139: 1313, 1979. 15) Sheets RF. The sequential occurrence of acute thyroiditis and thyrotoxicosis. JAMA 157: 139, 1955. 2) Fentiman IS, Thomas BS, Balkwill FR, Rubens RD, Hayward JL. Primary hypothyroidism associated with interferon therapy of breast cancer. Lancet 1166, 1985. 9) Kasagi K, Konishi J, Arai K, et al. A sensitive and practical assay for thyroid-stimulating antibodies using crude immunoglobulin fractions precipitated with polyethylene glycol. J Clin Endocrinol Metab 62: 855, 1986. |
References_xml | |
SSID | ssj0038792 |
Score | 1.5129777 |
Snippet | We report a case of Graves' hyperthyroidism induced by long-term interferon (IFN) therapy.A 52-year-old woman suffered from chronic active hepatitis type C and... We report a case of Graves' hyperthyroidism induced by long-term interferon (IFN) therapy. A 52-year-old woman suffered from chronic active hepatitis type C... |
SourceID | crossref pubmed pascalfrancis jstage |
SourceType | Aggregation Database Index Database Publisher |
StartPage | 58 |
SubjectTerms | Autoantibodies - blood autoimmunity Biological and medical sciences Drug toxicity and drugs side effects treatment Female Graves Disease - chemically induced Graves Disease - immunology Hepatitis C - drug therapy Hepatitis C - immunology Hepatitis, Chronic - drug therapy Hepatitis, Chronic - immunology Humans Interferon-alpha - adverse effects Interferon-alpha - immunology Medical sciences Middle Aged Miscellaneous (drug allergy, mutagens, teratogens...) Pharmacology. Drug treatments Radioimmunoassay Receptors, Thyrotropin - immunology Thyrotoxicosis - complications TSH-receptor antibody |
Title | Graves' Hyperthyroidism Following Transient Thyrotoxicosis during Interferon Therapy for Chronic Hepatitis Type C |
URI | https://www.jstage.jst.go.jp/article/internalmedicine1992/34/1/34_1_58/_article/-char/en https://www.ncbi.nlm.nih.gov/pubmed/7718983 |
Volume | 34 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
ispartofPNX | Internal Medicine, 1995, Vol.34(1), pp.58-60 |
link | http://sdu.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1bb9MwFLa6gRASQtwmCgz5AYkHlK2xndtjtXakmsYemkqIlygXm3WTmtGLtp_PObbjXsYDIHiJKseJnHxfzy0-5xDyIWRJWTIuvJLjZ8akVl5ZF4kXqVgFFSjEosCAWzqOvnyNB0Mx7HTaYp_rsf-KNIwB1pg5-wdou5vCAPwGzOEIqMPxt3D_jP2E9NaIFFzMOeAwb6Y1tsI4BcibWwwNaAWFiZCfMjy9bO6AD1iZxCYt6jChknNgRmaqDujdiLaQLqgq3Ia9hPnoxdo469V6S7y2cM93PtqfXYy-Tc5HOtp6Of0ur6cO6_44HV1oXVAsVo0bhvl6NAWhs7jcmJ6NJ4O-FmrX03mxjltgHrjjmM55A0sAO2y6vak2b-b-Am2w0sdcESuppRHVXAClmCl20spyGxjd5KwRzEG8oeJNB4Nd5cH8EGuvTu0y2r0NR1wctVdvFea2EOe7F-CG3pyL3DeHIM7bmZhIBxzdIw8YiEXstzEYnbV2A48j3cLbPavJZ8dVHf96TVum1MMr8CawTMSTm2IBf29l-rLseEvaasqekafW3aF9s7TnpCNnL8ij9tW_JD8MXT_SHbJSR1bqyEq3yUoNWemarNSSlQJZqSUrdWSlSFZ68opMTofZSerZLiBeBdpk6fkVePQF50xxyRSID4bp5BUHERiJMKyjgle9GtQ0l7wM4rDnF7UCxRIplvSSnuQHZH_WzORrQgMJ5rLwIxXGsfDLsqwEg0ukVFLImhVdcty-0PzGFHvJwUlGCO6hjOAGcZek5r27-X_Nii453ELO3ZGLKBQ90SUHBkl3IgK7Mon5m3-3hrfksSnZgCHGd2R_OV_JQ7K3qFfvNVd_AqJG6hc |
link.rule.ids | 315,782,786,4028,27932,27933,27934 |
linkProvider | Flying Publisher |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Graves%27+Hyperthyroidism+Following+Transient+Thyrotoxicosis+during+Interferon+Therapy+for+Chronic+Hepatitis+Type+C&rft.jtitle=Internal+Medicine&rft.au=KOIZUMI%2C+Shigeki&rft.au=MASHIO%2C+Yasuo&rft.au=MIZUO%2C+Hitoshi&rft.au=MATSUDA%2C+Akira&rft.date=1995&rft.pub=The+Japanese+Society+of+Internal+Medicine&rft.issn=0918-2918&rft.eissn=1349-7235&rft.volume=34&rft.issue=1&rft.spage=58&rft.epage=60&rft_id=info:doi/10.2169%2Finternalmedicine.34.58&rft.externalDocID=article_internalmedicine1992_34_1_34_1_58_article_char_en |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0918-2918&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0918-2918&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0918-2918&client=summon |